Recent reports show a significant gap in how different countries treat opioid addiction. This is especially clear when looking at the rise of dangerous additives in illegal drugs in the United States and the growth of government-funded treatment programs in India.

最近的報告顯示，不同國家處理鴉片類藥物成癮的方法有顯著差距。特別是在觀察美國非法藥物中危險添加劑的增加，以及印度政府資助治療計劃的成長時，這一點尤為明顯。

In the United States, a powerful tranquilizer called medetomidine is being mixed into illegal opioids. This has caused complex withdrawal symptoms that start quickly and can lead to serious heart problems. According to the CDC, this additive is found in many areas, particularly in the Northeast. In prisons, the lack of standard medical rules and a shortage of specialized medicines have led to dangerous outcomes, including heart attacks and deaths. Furthermore, the Federal Medicaid Inmate Exclusion Policy prevents federal funding for prisoners, which means local counties must pay for care. Consequently, providing medical treatment has become a difficult political issue.

在美國，一種名為 medetomidine 的強效鎮靜劑被混入非法鴉片類藥物中。這導致了複雜的戒斷症狀，且發作迅速，可能導致嚴重的心臟問題。根據 CDC 的說法，這種添加劑在許多地區被發現，尤其是在東北部。在監獄中，由於缺乏標準醫療準則以及專科藥物短缺，導致了危險的結果，包括心臟病發與死亡。此外，聯邦 Medicaid 囚犯排除政策禁止聯邦資金用於囚犯，這意味著地方郡政府必須支付醫療費用。因此，提供醫療治療已成為一個困難的政治議題。

In contrast, the state of Punjab, India, has taken a different approach through the 'Yudh Nashian Virudh' campaign. The government has opened several Methadone Maintenance Therapy (MMT) clinics in districts like Ludhiana and Patiala. These centers use a team-based model that includes supervised medication, psychiatric help, and counseling, following international health guidelines. This strategy combines strict law enforcement against drugs with medical treatments designed to help patients return to society.

相比之下，印度旁遮普邦透過「Yudh Nashian Virudh」運動採取了不同的做法。政府在 Ludhiana 和 Patiala 等地區開設了數間美沙酮維持治療 (MMT) 診所。這些中心採用團隊模式，包括監督用藥、精神科協助與諮詢，並遵循國際健康指南。此策略將嚴厲打擊毒品的執法與旨在幫助患者重返社會的醫療治療相結合。

Meanwhile, some US prisons have improved their results by partnering with medical universities. For example, the Allegheny County Jail worked with the University of Pittsburgh Medical Center to use research-based methods and special funding to provide medications like buprenorphine. However, these successes are only found in a few places. Many rural jails still cannot tell the difference between a normal opioid withdrawal and one caused by medetomidine, often realizing there is a problem only after standard treatments fail.

與此同時，部分美國監獄透過與醫科大學合作改善了結果。例如，Allegheny County Jail 與匹茲堡大學醫療中心合作，利用基於研究的方法與特別資金提供如 buprenorphine 等藥物。然而，這些成功僅出現在少數地方。許多鄉村監獄仍無法分辨一般的鴉片類藥物戒斷與 medetomidine 引起的戒斷，通常在標準治療失敗後才意識到問題所在。

While some regions are developing successful, state-funded treatment systems, others are facing a growing health crisis in prisons due to new drug additives and limited funding.

雖然部分地區正在發展成功的政府資助治療系統，但其他地區由於新藥物添加劑與資金有限，正於監獄面臨日益嚴重的健康危機。